| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.TRECAN.2019.07.002 |
| P698 | PubMed publication ID | 31421905 |
| P2093 | author name string | Satchidananda Panda | |
| Gabriele Sulli | |||
| Michael Tun Yin Lam | |||
| P2860 | cites work | A large scale shRNA barcode screen identifies the circadian clock component ARNTL as putative regulator of the p53 tumor suppressor pathway | Q21562478 |
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| Coupling of human circadian and cell cycles by the timeless protein | Q24299164 | ||
| p53 regulates Period2 expression and the circadian clock | Q24336862 | ||
| Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists | Q24629345 | ||
| The emerging roles of melanopsin in behavioral adaptation to light | Q24633234 | ||
| Circadian control of the immune system | Q27023060 | ||
| Depletion of white adipose tissue in cancer cachexia syndrome is associated with inflammatory signaling and disrupted circadian regulation | Q27312755 | ||
| The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo | Q28206180 | ||
| The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation | Q28261349 | ||
| Circadian genes and breast cancer susceptibility in rotating shift workers | Q28387050 | ||
| Modulation of ATR-mediated DNA damage checkpoint response by cryptochrome 1 | Q28506381 | ||
| Poly(ADP-ribose) polymerase 1 participates in the phase entrainment of circadian clocks to feeding | Q28587849 | ||
| Model-driven experimental approach reveals the complex regulatory distribution of p53 by the circadian factor Period 2 | Q28818349 | ||
| A functional genomics strategy reveals Rora as a component of the mammalian circadian clock | Q29616297 | ||
| Enhancing circadian clock function in cancer cells inhibits tumor growth | Q30838731 | ||
| Sleep and cancer: Synthesis of experimental data and meta-analyses of cancer incidence among some 1,500,000 study individuals in 13 countries | Q31061663 | ||
| Circadian clock cryptochrome proteins regulate autoimmunity | Q46273899 | ||
| Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis | Q47110918 | ||
| Circadian disruption and fatal ovarian cancer | Q48126535 | ||
| Control mechanism of the circadian clock for timing of cell division in vivo | Q48219610 | ||
| Acute inhibition of casein kinase 1δ/ε rapidly delays peripheral clock gene rhythms | Q48524755 | ||
| Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescence | Q48543236 | ||
| Night shift work and breast cancer: a pooled analysis of population-based case-control studies with complete work history | Q49722295 | ||
| Diurnal transcriptome atlas of a primate across major neural and peripheral tissues | Q50036475 | ||
| Immune-Related Adverse Events Associated with Immune Checkpoint Blockade | Q50103276 | ||
| Breast cancer risk, nightwork, and circadian clock gene polymorphisms | Q51080101 | ||
| Reciprocal Regulation between the Circadian Clock and Hypoxia Signaling at the Genome Level in Mammals. | Q51367975 | ||
| Circadian Clock Interaction with HIF1α Mediates Oxygenic Metabolism and Anaerobic Glycolysis in Skeletal Muscle | Q51367982 | ||
| The circadian molecular clock creates epidermal stem cell heterogeneity | Q51847597 | ||
| A synthetic cryptochrome inhibitor induces anti-proliferative effects and increases chemosensitivity in human breast cancer cells | Q52148828 | ||
| Light-induced suppression of endogenous circadian amplitude in humans | Q52448094 | ||
| Cryptochrome, circadian cycle, cell cycle checkpoints, and cancer | Q52565548 | ||
| Telomerase reconstitution contributes to resetting of circadian rhythm in fibroblasts. | Q52586235 | ||
| A proteomics landscape of circadian clock in mouse liver. | Q52718144 | ||
| The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer Chronotherapy. | Q52727400 | ||
| Galectin-9 promotes TGF-β1-dependent induction of regulatory T cells via the TGF-β/Smad signaling pathway | Q54477665 | ||
| Human epidermal stem cell function is regulated by circadian oscillations. | Q54769628 | ||
| Non-Metastatic Cutaneous Melanoma Induces Chronodisruption in Central and Peripheral Circadian Clocks. | Q55096289 | ||
| Expression of the Circadian Clock Gene BMAL1 Positively Correlates With Antitumor Immunity and Patient Survival in Metastatic Melanoma. | Q55363579 | ||
| Night work and prostate cancer risk: results from the EPICAP Study | Q57565039 | ||
| Circadian clock protein BMAL1 regulates IL-1β in macrophages via NRF2 | Q58733733 | ||
| Circadian rest-activity rhythm as an objective biomarker of patient-reported outcomes in patients with advanced cancer | Q58796654 | ||
| Effect of mistimed eating patterns on breast and prostate cancer risk (MCC-Spain Study) | Q58886998 | ||
| The Circadian Clock Controls Immune Checkpoint Pathway in Sepsis | Q61631793 | ||
| Cell-based screen identifies a new potent and highly selective CK2 inhibitor for modulation of circadian rhythms and cancer cell growth | Q61811447 | ||
| G1/S cell cycle regulators mediate effects of circadian dysregulation on tumor growth and provide targets for timed anticancer treatment | Q64080120 | ||
| Rotating night shift work and colorectal cancer risk in the nurses' health studies | Q66475538 | ||
| Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial | Q72732640 | ||
| Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy | Q73685231 | ||
| Diurnal cortisol rhythm as a predictor of breast cancer survival | Q73911071 | ||
| Randomized Phase III Trial of Standard Timed Doxorubicin Plus Cisplatin Versus Circadian Timed Doxorubicin Plus Cisplatin in Stage III and IV or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study | Q79150759 | ||
| Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment | Q80025874 | ||
| Cellular senescence impairs circadian expression of clock genes in vitro and in vivo | Q82312042 | ||
| Clocking in to immunity | Q88377323 | ||
| In Vitro Priming of Adoptively Transferred T Cells with a RORγ Agonist Confers Durable Memory and Stemness In Vivo | Q88697390 | ||
| Acid Suspends the Circadian Clock in Hypoxia through Inhibition of mTOR | Q88964560 | ||
| Generation of circadian rhythms in the suprachiasmatic nucleus | Q89207654 | ||
| Autophagy Regulates the Liver Clock and Glucose Metabolism by Degrading CRY1 | Q89224112 | ||
| Training the Circadian Clock, Clocking the Drugs, and Drugging the Clock to Prevent, Manage, and Treat Chronic Diseases | Q90642449 | ||
| Crosstalk between metabolism and circadian clocks | Q91011199 | ||
| Atlas of Circadian Metabolism Reveals System-wide Coordination and Communication between Clocks | Q91332011 | ||
| Shift Work Patterns, Chronotype, and Epithelial Ovarian Cancer Risk | Q92176577 | ||
| A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma | Q92905126 | ||
| Distinct control of PERIOD2 degradation and circadian rhythms by the oncoprotein and ubiquitin ligase MDM2 | Q93052159 | ||
| Long-Term Endocrine and Metabolic Consequences of Cancer Treatment: A Systematic Review | Q93369612 | ||
| Circadian oscillation of nucleotide excision repair in mammalian brain | Q33402391 | ||
| Systems Chronotherapeutics | Q33573675 | ||
| GSK4112, a Small Molecule Chemical Probe for the Cell Biology of the Nuclear Heme Receptor Rev-erbα | Q33647307 | ||
| Intercellular Coupling of the Cell Cycle and Circadian Clock in Adult Stem Cell Culture | Q33652780 | ||
| Ras-mediated deregulation of the circadian clock in cancer | Q33685542 | ||
| CYCLOPS reveals human transcriptional rhythms in health and disease | Q33719425 | ||
| Remote reprogramming of hepatic circadian transcriptome by breast cancer | Q33798291 | ||
| Circadian variation of cell proliferation and cell cycle protein expression in man: clinical implications | Q33877749 | ||
| Nuclear retention of Fbw7 by specific inhibitors of nuclear export leads to Notch1 degradation in pancreatic cancer | Q33976883 | ||
| Period 2 mutation accelerates ApcMin/+ tumorigenesis | Q34060495 | ||
| Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β | Q34264573 | ||
| Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia | Q34268301 | ||
| NONO couples the circadian clock to the cell cycle | Q34319589 | ||
| The circadian factor Period 2 modulates p53 stability and transcriptional activity in unstressed cells | Q34504101 | ||
| The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells | Q34522359 | ||
| Rhythmic Oxygen Levels Reset Circadian Clocks through HIF1α. | Q34543299 | ||
| CRY2 and FBXL3 Cooperatively Degrade c-MYC. | Q34544579 | ||
| Association of the circadian factor Period 2 to p53 influences p53's function in DNA-damage signaling | Q34960791 | ||
| DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization | Q35156678 | ||
| AKT and TOR signaling set the pace of the circadian pacemaker | Q35191036 | ||
| Prolonged Nightly Fasting and Breast Cancer Risk: Findings from NHANES (2009-2010). | Q35563100 | ||
| The adipocyte clock controls brown adipogenesis through the TGF-β and BMP signaling pathways | Q35657960 | ||
| The nuclear receptor REV-ERBα mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines. | Q35673857 | ||
| Circadian control of innate immunity in macrophages by miR-155 targeting Bmal1. | Q35740315 | ||
| The circadian mutation PER2(S662G) is linked to cell cycle progression and tumorigenesis | Q35754678 | ||
| Chronic Shift-Lag Alters the Circadian Clock of NK Cells and Promotes Lung Cancer Growth in Rats | Q35803377 | ||
| Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy | Q35849866 | ||
| Immunity, inflammation, and cancer: an eternal fight between good and evil | Q36106053 | ||
| The Emerging Hallmarks of Cancer Metabolism | Q36468964 | ||
| Therapeutic targeting of casein kinase 1δ in breast cancer | Q36734385 | ||
| MYC Disrupts the Circadian Clock and Metabolism in Cancer Cells. | Q36760018 | ||
| Core Circadian Clock Genes Regulate Leukemia Stem Cells in AML | Q36783304 | ||
| Local circadian clock gates cell cycle progression of transient amplifying cells during regenerative hair cycling | Q36915650 | ||
| Circadian Rhythm Connections to Oxidative Stress: Implications for Human Health | Q36945752 | ||
| Circadian Amplitude Regulation via FBXW7-Targeted REV-ERBα Degradation | Q37017288 | ||
| Loss of cryptochrome reduces cancer risk in p53 mutant mice | Q37081282 | ||
| Nightshift work and risk of ovarian cancer | Q37184554 | ||
| ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer | Q37270422 | ||
| Period2 downregulation inhibits glioma cell apoptosis by activating the MDM2-TP53 pathway | Q37317259 | ||
| Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. | Q37340291 | ||
| Disruption of the circadian clock due to the Clock mutation has discrete effects on aging and carcinogenesis. | Q37347756 | ||
| Chronotherapy: Intuitive, Sound, Founded…But Not Broadly Applied. | Q37371203 | ||
| The polarization of immune cells in the tumour environment by TGFbeta | Q37454364 | ||
| Time of feeding and the intrinsic circadian clock drive rhythms in hepatic gene expression | Q37482097 | ||
| Deficiency in PER proteins has no effect on the rate of spontaneous and radiation-induced carcinogenesis | Q37521405 | ||
| Nuclear Proteomics Uncovers Diurnal Regulatory Landscapes in Mouse Liver. | Q37590445 | ||
| Analysis of polymorphisms in the circadian-related genes and breast cancer risk in Norwegian nurses working night shifts. | Q37690194 | ||
| Cross-talk between the circadian clock and the cell cycle in cancer. | Q38208057 | ||
| Immune evasion in cancer: Mechanistic basis and therapeutic strategies. | Q38394302 | ||
| Carcinogenicity of shift-work, painting, and fire-fighting | Q38459347 | ||
| c-MYC targets the central oscillator gene Per1 and is regulated by the circadian clock at the post-transcriptional level | Q38796104 | ||
| The circadian clock gene Bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathway | Q38810579 | ||
| Immunity around the clock | Q39019210 | ||
| A circadian clock gene, Rev-erbα, modulates the inflammatory function of macrophages through the negative regulation of Ccl2 expression. | Q39048460 | ||
| Molecular basis for the regulation of the circadian clock kinases CK1δ and CK1ε. | Q39069046 | ||
| Rhythmic Control of the ARF-MDM2 Pathway by ATF4 Underlies Circadian Accumulation of p53 in Malignant Cells | Q39167493 | ||
| Ras Activity Tunes the Period and Modulates the Entrainment of the Suprachiasmatic Clock | Q39397684 | ||
| Phase resetting of the mammalian circadian clock by DNA damage | Q40010406 | ||
| A randomized multicenter study of optimal circadian time of vinorelbine combined with chronomodulated 5-fluorouracil in pretreated metastatic breast cancer patients: EORTC trial 05971. | Q40049440 | ||
| The Small Molecule Nobiletin Targets the Molecular Oscillator to Enhance Circadian Rhythms and Protect against Metabolic Syndrome. | Q40204797 | ||
| Circadian CLOCK Mediates Activation of Transforming Growth Factor-β Signaling and Renal Fibrosis through Cyclooxygenase 2. | Q40440996 | ||
| Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity | Q40806737 | ||
| Circadian rhythm of cell division | Q41744117 | ||
| TH17 cell differentiation is regulated by the circadian clock. | Q41809497 | ||
| Circadian gene Bmal1 regulates diurnal oscillations of Ly6C(hi) inflammatory monocytes. | Q41850578 | ||
| Circadian Rhythm Disruption Promotes Lung Tumorigenesis | Q41921459 | ||
| Clock gene Per2 as a controller of liver carcinogenesis | Q42003261 | ||
| The circadian rhythm controls telomeres and telomerase activity | Q42202464 | ||
| The circadian clock Period 2 gene regulates gamma interferon production of NK cells in host response to lipopolysaccharide-induced endotoxic shock. | Q42277396 | ||
| Lung Adenocarcinoma Distally Rewires Hepatic Circadian Homeostasis | Q42293291 | ||
| Reciprocal interaction between the suprachiasmatic nucleus and the immune system tunes down the inflammatory response to lipopolysaccharide | Q42460414 | ||
| PI3K regulates BMAL1/CLOCK-mediated circadian transcription from the Dbp promoter | Q42812320 | ||
| Triggering Fbw7-mediated proteasomal degradation of c-Myc by oridonin induces cell growth inhibition and apoptosis. | Q43508536 | ||
| Host circadian clock as a control point in tumor progression. | Q43976271 | ||
| Diurnal cortisol rhythm as a predictor of lung cancer survival. | Q44449313 | ||
| The Ink4a/Arf locus operates as a regulator of the circadian clock modulating RAS activity. | Q45943215 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 475-494 | |
| P577 | publication date | 2019-08-03 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Trends in cancer | Q27726777 |
| P1476 | title | Interplay between Circadian Clock and Cancer: New Frontiers for Cancer Treatment | |
| P478 | volume | 5 |
| Q98735568 | Innate Rhythms: Clocks at the Center of Monocyte and Macrophage Function |
| Q90483971 | Insights About Circadian Clock and Molecular Pathogenesis in Gliomas |
| Q89607086 | Mechanistic understanding of β-cryptoxanthin and lycopene in cancer prevention in animal models |
| Q89497345 | The Multifaceted Role of Heme in Cancer |
| Q96303179 | The circadian clock gene Bmal1 facilitates cisplatin-induced renal injury and hepatization |
| Q90498634 | Time after time: circadian clock regulation of intestinal stem cells |
Search more.